AstraZeneca (AZN) announced an update on their ongoing clinical study. AstraZeneca Advances Mid-Stage Rheumatoid Arthritis Trial With AZD1163 Study Overview: AstraZeneca is running a Phase II trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results